The Helmholtz Center for Infection Research, based in Braunschweig, is a member of the Helmholtz Association and conducts cutting-edge research in the field of infectious diseases. Our scientists develop novel methods and strategies to combat infectious diseases more quickly and effectively. Our common goal is to develop novel approaches to the prevention, diagnosis, and treatment of infectious diseases. Our research focuses on bacterial and viral pathogens, their interaction with the human immune system, and new effective drugs and vaccines.

The Core Facility for Translational Proteomics (CFTP) supports scientists in deciphering protein-based mechanisms of infection and immunity. It offers expertise, state-of-the-art technologies, and analytical tools to (i) identify proteins involved in host-pathogen interactions, (ii) discover biomarkers for infections and immune responses, and (iii) characterize target structures for therapeutic development. We offer protein and proteome analyses as a complete service and in collaborative projects, combining many years of expertise in protein biochemistry, mass spectrometry (MS), and biostatistics.

This research center is part of the Helmholtz Association of German Research Centers. With more than 42,000 employees and an annual budget of over € 5 billion, the Helmholtz Association is Germany's largest scientific organisation.